Matthew James Woodward, MD | |
22 S Greene St Rm N3e09, Baltimore, MD 21201-1544 | |
(410) 328-6110 | |
Not Available |
Full Name | Matthew James Woodward |
---|---|
Gender | Male |
Speciality | Neurology |
Experience | 6 Years |
Location | 22 S Greene St Rm N3e09, Baltimore, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114423274 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0400X | Psychiatry & Neurology - Neurology | DR.0068397 (Colorado) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Colorado Hospital Authority | Aurora, CO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Physicians Incorporated | 3476465667 | 2657 |
News Archive
Presidio Pharmaceuticals, Inc. announced today positive preliminary results from a Phase 1b clinical trial of PPI-461, a novel HCV NS5A inhibitor for the treatment of patients with chronic hepatitis C.
SuperSonic Imagine, the innovative producer of ultrasound equipment, announced today that it has signed an exclusive distribution agreement with Hologic, Inc. to develop the breast ultrasound market in the United States.
A new device designed to perform safer, more effective cataract surgery is going on the market following a licensing agreement between the University of Colorado and Mile High Ophthalmics LLC.
Declarative memory - memories that can be consciously recalled - is critical to everyday life. Throughout childhood and adolescence, declarative memory improves remarkably. However, until most recently, there was a critical gap in our understanding of how maturation of the prefrontal cortex drives memory development.
Switching anti-psychotic medications does not improve clinical outcomes in patients with first-episode schizophrenia who haven't responded to treatment, Mount Sinai researchers have shown for the first time.
› Verified 6 days ago
Entity Name | Denver Health And Hospital Authority |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477569838 PECOS PAC ID: 4688583578 Enrollment ID: O20031105000211 |
News Archive
Presidio Pharmaceuticals, Inc. announced today positive preliminary results from a Phase 1b clinical trial of PPI-461, a novel HCV NS5A inhibitor for the treatment of patients with chronic hepatitis C.
SuperSonic Imagine, the innovative producer of ultrasound equipment, announced today that it has signed an exclusive distribution agreement with Hologic, Inc. to develop the breast ultrasound market in the United States.
A new device designed to perform safer, more effective cataract surgery is going on the market following a licensing agreement between the University of Colorado and Mile High Ophthalmics LLC.
Declarative memory - memories that can be consciously recalled - is critical to everyday life. Throughout childhood and adolescence, declarative memory improves remarkably. However, until most recently, there was a critical gap in our understanding of how maturation of the prefrontal cortex drives memory development.
Switching anti-psychotic medications does not improve clinical outcomes in patients with first-episode schizophrenia who haven't responded to treatment, Mount Sinai researchers have shown for the first time.
› Verified 6 days ago
Entity Name | University Physicians Incorporated |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962461889 PECOS PAC ID: 3476465667 Enrollment ID: O20031105000375 |
News Archive
Presidio Pharmaceuticals, Inc. announced today positive preliminary results from a Phase 1b clinical trial of PPI-461, a novel HCV NS5A inhibitor for the treatment of patients with chronic hepatitis C.
SuperSonic Imagine, the innovative producer of ultrasound equipment, announced today that it has signed an exclusive distribution agreement with Hologic, Inc. to develop the breast ultrasound market in the United States.
A new device designed to perform safer, more effective cataract surgery is going on the market following a licensing agreement between the University of Colorado and Mile High Ophthalmics LLC.
Declarative memory - memories that can be consciously recalled - is critical to everyday life. Throughout childhood and adolescence, declarative memory improves remarkably. However, until most recently, there was a critical gap in our understanding of how maturation of the prefrontal cortex drives memory development.
Switching anti-psychotic medications does not improve clinical outcomes in patients with first-episode schizophrenia who haven't responded to treatment, Mount Sinai researchers have shown for the first time.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Matthew James Woodward, MD 22 S Greene St Rm N3e09, Baltimore, MD 21201-1544 Ph: (410) 328-6110 | Matthew James Woodward, MD 22 S Greene St Rm N3e09, Baltimore, MD 21201-1544 Ph: (410) 328-6110 |
News Archive
Presidio Pharmaceuticals, Inc. announced today positive preliminary results from a Phase 1b clinical trial of PPI-461, a novel HCV NS5A inhibitor for the treatment of patients with chronic hepatitis C.
SuperSonic Imagine, the innovative producer of ultrasound equipment, announced today that it has signed an exclusive distribution agreement with Hologic, Inc. to develop the breast ultrasound market in the United States.
A new device designed to perform safer, more effective cataract surgery is going on the market following a licensing agreement between the University of Colorado and Mile High Ophthalmics LLC.
Declarative memory - memories that can be consciously recalled - is critical to everyday life. Throughout childhood and adolescence, declarative memory improves remarkably. However, until most recently, there was a critical gap in our understanding of how maturation of the prefrontal cortex drives memory development.
Switching anti-psychotic medications does not improve clinical outcomes in patients with first-episode schizophrenia who haven't responded to treatment, Mount Sinai researchers have shown for the first time.
› Verified 6 days ago
Dr. Michelle Schnabel Horner, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5500 E Lombard St, Baltimore, MD 21224 Phone: 410-550-0091 | |
Dr. Priscilla Waldo Sheldon, M.D., PH.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1001 W Pratt St, Baltimore, MD 21223 Phone: 410-962-7180 Fax: 410-962-7194 | |
Haopeng Zheng, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 345 Saint Paul Pl, Baltimore, MD 21202 Phone: 410-332-9000 | |
Ms. Sarah Catherine Collica, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 600 North Wolfe St, Baltimore, MD 21287 Phone: 410-955-5000 | |
Abdullah Bin Zahid, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 600 N Wolfe Street Phipps 455, Baltimore, MD 21264 Phone: 410-933-6423 | |
Chelsea Cosner, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 701 W Pratt St Rm 474, Baltimore, MD 21201 Phone: 410-328-6325 | |
Michael Andre Torres, M.D. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 600 Wyndhurst Ave, Suite 160, Baltimore, MD 21210 Phone: 410-617-0605 Fax: 443-773-1406 |